Duo-Vil (amitriptyline / perphenazine) Drug Interactions
A total of 1276 drugs (7307 brand and generic names) are known to interact with Duo-Vil (amitriptyline / perphenazine).
- 367 major drug interactions (2574 brand and generic names)
- 834 moderate drug interactions (4108 brand and generic names)
- 75 minor drug interactions (625 brand and generic names)
Common medications checked in combination with Duo-Vil (amitriptyline / perphenazine)
- Adderall (amphetamine / dextroamphetamine)
- CoQ10 (ubiquinone)
- Coreg (carvedilol)
- Effexor (venlafaxine)
- Focalin XR (dexmethylphenidate)
- Lexapro (escitalopram)
- Methylin (methylphenidate)
- Paxil (paroxetine)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Strattera (atomoxetine)
- Xanax (alprazolam)
- Zyrtec (cetirizine)
Check for interactions with Duo-Vil (amitriptyline / perphenazine)
Duo-Vil (amitriptyline / perphenazine) alcohol/food Interactions
There is 1 alcohol/food interaction with Duo-Vil (amitriptyline / perphenazine)
Duo-Vil (amitriptyline / perphenazine) disease Interactions
There are 37 disease interactions with Duo-Vil (amitriptyline / perphenazine) which include:
- Dementia
- Liver Damage
- Acute Alcohol Intoxication
- Cardiovascular Disease
- Cns Depression
- Head Injury
- Anticholinergic Effects
- Cardiovascular Disease
- Pheochromocytoma
- Acute Myocardial Infarction Recovery
- Cardiovascular Disease
- Depression
- Seizure Disorders
- Anticholinergic Effects
- Breast Cancer
- Dystonic Reactions
- Hematologic Toxicity
- Nms
- Parkinsonism
- Renal Dysfunction
- Respiratory Disorders
- Seizure Disorders
- Tardive Dyskinesia
- Bone Marrow Suppression
- Diabetes
- Renal/Liver Disease
- Schizophrenia/Bipolar Disorder
- Tardive Dyskinesia
- Acute Alcohol Intoxication
- Bipolar Disorder Screening
- Glaucoma
- Hyper/Hypoglycemia
- Liver/Renal Disease
- Neutropenia
- Schizophrenia
- Thyroid Disorders
- Urinary Retention
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2018 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
